Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040586
Status:
COMPLETED
Last Update Posted:
2007-01-22
First Post:
2002-07-01
Brief Title:
Phase II Trial of Monoclonal Antibody J591 in Combination With Low-Dose Subcutaneous Interleukin-2
Sponsor:
Organization:
BZL Biologics